BODIPY Nanoparticles Functionalized With Lactose for Cancer-Targeted and Fluorescence Imaging-guided Photodynamic Therapy
Abstract A series of four lactose-modified BODIPY photosensitizers (PSs) with different substituents (-I, -H, -OCH3, and -NO2) in the para-phenyl moiety attached to the meso-position of the BODIPY core were synthesized; the photophysical properties and photodynamic anticancer activities of these sensitizers were investigated, focusing on the electronic properties of the different substituent groups. Iodine substitution (BODIPY I) enhanced the intersystem crossing (ISC) to produce singlet oxygen (1O2) due to the heavy atom effect, and maintained a high fluorescence quantum yield (ΦF) of 45.3%. Substitution with the electron-donating group (-OCH3) (BODIPY OMe) resulted in a high 1O2 generation capability and a ΦF of 49.2% while substitution with the electron-withdrawing group (-NO2) led to the PeT process. Thus, instead of assisting ISC as typically expected, this BODIPY PS induced non-radiative charge recombination, prohibiting both fluorescence emission and 1O2 generation. The BODIPY PSs formed water-soluble nanoparticles (NPs) functionalized with lactose as liver cancer-targeting ligands. BODIPY I and OMe NPs showed good fluorescence imaging and PDT activity against various tumor cells (HeLa and Huh-7 cells). Collectively, the BODIPY NPs demonstrated high 1O2 generation capability and ΦF may create a new opportunity to develop useful imaging-guided PDT agents for tumor cells.